Gary P Toedter

Title: Innovations by Gary P Toedter

Introduction

Gary P Toedter is a notable inventor based in Miramar, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to his name, Toedter's work has had a substantial impact on medical diagnostics.

Latest Patents

Toedter's latest patents include a monoclonal antibody for detecting HTLV-I, HTLV-II, and STLV-I viruses. This invention features a hybrid cell line capable of producing monoclonal antibodies that bind to HTLV-I and HTLV-II core antigens p24 and p53, while not binding to the p19 core antigen. The antibody, identified as the KC-88 monoclonal antibody, is crucial for research and diagnostic purposes. Additionally, he developed a monoclonal antibody specific to HIV antigens. This antibody binds to HIV core antigen P55 and core protein P24, while avoiding binding to the P18 core protein or any HIV envelope antigens. The KC-57 antibody, as it is known, is particularly useful for solid phase immunoassays in human serum or plasma samples.

Career Highlights

Gary P Toedter has worked at Coulter Corporation, where he has been able to apply his expertise in immunology and biotechnology. His innovative approaches have led to advancements in the detection of viral infections, which are critical for public health.

Collaborations

Toedter has collaborated with notable colleagues such as David E Hofheinz and Kenneth H Kortright. These partnerships have fostered a collaborative environment that enhances research and development in their field.

Conclusion

Gary P Toedter's contributions to the field of biotechnology through his patents and collaborations have made a significant impact on medical diagnostics. His work continues to influence the development of innovative solutions for detecting viral infections.